210 related articles for article (PubMed ID: 36581470)
41. PMP22 Regulates Self-Renewal and Chemoresistance of Gastric Cancer Cells.
Cai W; Chen G; Luo Q; Liu J; Guo X; Zhang T; Ma F; Yuan L; Li B; Cai J
Mol Cancer Ther; 2017 Jun; 16(6):1187-1198. PubMed ID: 28336807
[TBL] [Abstract][Full Text] [Related]
42. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
43. The downregulation of WWOX induces epithelial-mesenchymal transition and enhances stemness and chemoresistance in breast cancer.
Li J; Liu J; Li P; Zhou C; Liu P
Exp Biol Med (Maywood); 2018 Sep; 243(13):1066-1073. PubMed ID: 30335523
[TBL] [Abstract][Full Text] [Related]
44. CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma.
Liu F; Huang J; He F; Ma X; Fan F; Meng M; Zhuo Y; Zhang L
Sci Rep; 2020 Jul; 10(1):10768. PubMed ID: 32612110
[TBL] [Abstract][Full Text] [Related]
45. The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor-infiltrating T cells.
Lepletier A; Lutzky VP; Mittal D; Stannard K; Watkins TS; Ratnatunga CN; Smith C; McGuire HM; Kemp RA; Mukhopadhyay P; Waddell N; Smyth MJ; Dougall WC; Miles JJ
Immunol Cell Biol; 2019 Feb; 97(2):152-164. PubMed ID: 30222899
[TBL] [Abstract][Full Text] [Related]
46. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
[TBL] [Abstract][Full Text] [Related]
47. Fatty acid β-oxidation promotes breast cancer stemness and metastasis via the miRNA-328-3p-CPT1A pathway.
Zeng F; Yao M; Wang Y; Zheng W; Liu S; Hou Z; Cheng X; Sun S; Li T; Zhao H; Luo Y; Li J
Cancer Gene Ther; 2022 Mar; 29(3-4):383-395. PubMed ID: 34045663
[TBL] [Abstract][Full Text] [Related]
48. Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade.
Zhang Z; Duan Q; Zhao H; Liu T; Wu H; Shen Q; Wang C; Yin T
Cancer Lett; 2016 Nov; 382(1):53-63. PubMed ID: 27576197
[TBL] [Abstract][Full Text] [Related]
49. TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer.
Maas RJ; Hoogstad-van Evert JS; Van der Meer JM; Mekers V; Rezaeifard S; Korman AJ; de Jonge PK; Cany J; Woestenenk R; Schaap NP; Massuger LF; Jansen JH; Hobo W; Dolstra H
Oncoimmunology; 2020 Nov; 9(1):1843247. PubMed ID: 33224630
[TBL] [Abstract][Full Text] [Related]
50. Mitochondrial and ribosomal biogenesis are new hallmarks of stemness, oncometabolism and biomass accumulation in cancer: Mito-stemness and ribo-stemness features.
Peiris-Pagès M; Ozsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2019 Jul; 11(14):4801-4835. PubMed ID: 31311889
[TBL] [Abstract][Full Text] [Related]
51. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
[TBL] [Abstract][Full Text] [Related]
52. NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer.
Zhu J; Wu G; Song L; Cao L; Tan Z; Tang M; Li Z; Shi D; Zhang S; Li J
EBioMedicine; 2019 May; 43():238-252. PubMed ID: 31047858
[TBL] [Abstract][Full Text] [Related]
53. Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.
Steg AD; Bevis KS; Katre AA; Ziebarth A; Dobbin ZC; Alvarez RD; Zhang K; Conner M; Landen CN
Clin Cancer Res; 2012 Feb; 18(3):869-81. PubMed ID: 22142828
[TBL] [Abstract][Full Text] [Related]
54. When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance.
Kuo CY; Ann DK
Cancer Commun (Lond); 2018 Jul; 38(1):47. PubMed ID: 29996946
[TBL] [Abstract][Full Text] [Related]
55. BCL9 regulates CD226 and CD96 checkpoints in CD8
Feng M; Wu Z; Zhou Y; Wei Z; Tian E; Mei S; Zhu Y; Liu C; He F; Li H; Xie C; Jin J; Dong J; Yang D; Yu K; Qian J; Lambrechts D; Wang MW; Zhu D
Signal Transduct Target Ther; 2021 Aug; 6(1):313. PubMed ID: 34417435
[TBL] [Abstract][Full Text] [Related]
56. The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.
Chan CJ; Martinet L; Gilfillan S; Souza-Fonseca-Guimaraes F; Chow MT; Town L; Ritchie DS; Colonna M; Andrews DM; Smyth MJ
Nat Immunol; 2014 May; 15(5):431-8. PubMed ID: 24658051
[TBL] [Abstract][Full Text] [Related]
57. BOP1 confers chemoresistance of triple-negative breast cancer by promoting CBP-mediated β-catenin acetylation.
Li S; Wu H; Huang X; Jian Y; Kong L; Xu H; Ouyang Y; Chen X; Wu G; Yu L; Wang X
J Pathol; 2021 Jul; 254(3):265-278. PubMed ID: 33797754
[TBL] [Abstract][Full Text] [Related]
58. Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids.
Li YJ; Fahrmann JF; Aftabizadeh M; Zhao Q; Tripathi SC; Zhang C; Yuan Y; Ann D; Hanash S; Yu H
Cell Rep; 2022 May; 39(9):110870. PubMed ID: 35649368
[TBL] [Abstract][Full Text] [Related]
59. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
60. TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy.
Dougall WC; Kurtulus S; Smyth MJ; Anderson AC
Immunol Rev; 2017 Mar; 276(1):112-120. PubMed ID: 28258695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
